Raras
Buscar doenças, sintomas, genes...
Síndrome nefrótica-doença pulmonar intersticial-epidermólise bolhosa
ORPHA:306504CID-10 · J84.8OMIM 614748PCDT · SUSDOENÇA RARA

Uma doença grave que afeta vários órgãos e pode ser fatal, que surge nos primeiros meses de vida. Ela se manifesta com dificuldade para respirar e perda grave de proteína na urina (um sinal característico da síndrome nefrótica), levando a uma doença grave que afeta o tecido dos pulmões e à falência dos rins. Além disso, alguns pacientes apresentam alterações na pele, que variam de bolhas e feridas na pele a um quadro parecido com a epidermólise bolhosa, com unhas dos pés deformadas e cabelo ralo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença grave que afeta vários órgãos e pode ser fatal, que surge nos primeiros meses de vida. Ela se manifesta com dificuldade para respirar e perda grave de proteína na urina (um sinal característico da síndrome nefrótica), levando a uma doença grave que afeta o tecido dos pulmões e à falência dos rins. Além disso, alguns pacientes apresentam alterações na pele, que variam de bolhas e feridas na pele a um quadro parecido com a epidermólise bolhosa, com unhas dos pés deformadas e cabelo ralo.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
3
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 30%
PCDT disponívelCID-10: J84.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
5 sintomas
🫁
Pulmão
5 sintomas
🧬
Pele e cabelo
4 sintomas
😀
Face
4 sintomas
🧠
Neurológico
3 sintomas
👁️
Olhos
2 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

100%prev.
Síndrome nefrótica
Frequência: 3/3
100%prev.
Glomeruloesclerose segmentar focal
Frequência: 3/3
100%prev.
Cabelo esparso no couro cabeludo
Frequência: 3/3
100%prev.
Distrofia ungueal
Frequência: 3/3
100%prev.
Desconforto respiratório
Frequência: 3/3
100%prev.
Onicólise
Obrigatório (100%)
35sintomas
Muito frequente (9)
Frequente (5)
Sem dados (21)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 35 características clínicas mais associadas, ordenadas por frequência.

Síndrome nefróticaNephrotic syndrome
Frequência: 3/3100%
Glomeruloesclerose segmentar focalFocal segmental glomerulosclerosis
Frequência: 3/3100%
Cabelo esparso no couro cabeludoSparse scalp hair
Frequência: 3/3100%
Distrofia unguealNail dystrophy
Frequência: 3/3100%
Desconforto respiratórioRespiratory distress
Frequência: 3/3100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Últimos 10 anos9publicações
Pico20162 papers
Linha do tempo
2025Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

ITGA3Integrin alpha-3Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Integrin alpha-3/beta-1 is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration (Microbial infection) Integrin ITGA3:I

LOCALIZAÇÃO

Cell membraneCell projection, invadopodium membraneCell projection, filopodium membrane

VIAS BIOLÓGICAS (4)
Basigin interactionsIntegrin cell surface interactionsMET activates PTK2 signalingLaminin interactions
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB7 is an autosomal recessive form associated with congenital nephrotic syndrome and interstitial lung disease. The respiratory and renal features predominate, and lung involvement accounts for the lethal course of the disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
186.8 TPM
Aorta
178.4 TPM
Artéria coronária
158.9 TPM
Pulmão
150.0 TPM
Tireoide
139.5 TPM
OUTRAS DOENÇAS (1)
epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
HGNC:6139UniProt:P26006

Medicamentos aprovados (FDA)

3 medicamentos encontrados nos registros da FDA americana.

💊 ACTEMRA (TOCILIZUMAB)
💊 TYVASO (TREPROSTINIL)
💊 Ofev (NINTEDANIB)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

60 variantes patogênicas registradas no ClinVar.

🧬 ITGA3: NM_002204.4(ITGA3):c.2577_2583+13del ()
🧬 ITGA3: NM_002204.4(ITGA3):c.1674+16G>A ()
🧬 ITGA3: NM_002204.4(ITGA3):c.1157-9C>G ()
🧬 ITGA3: NM_002204.4(ITGA3):c.1528C>T (p.Arg510Ter) ()
🧬 ITGA3: NM_002204.4(ITGA3):c.2641G>T (p.Gly881Ter) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

4 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome nefrótica-doença pulmonar intersticial-epidermólise bolhosa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

The Spectrum of Epidermolysis Bullosa in KwaZulu-Natal, South Africa.

International journal of dermatology2025 Aug

Epidermolysis bullosa (EB) is a rare, heterogeneous genodermatosis characterized by skin fragility due to inherited defects in genes encoding proteins that maintain epidermal-dermal integrity. The severity and complications of EB vary by subtype, and no cure currently exists. The epidemiology is unknown in South Africa. This prospective observational study in KwaZulu-Natal correlated African Zulu EB patients' phenotypic features with genotypic and histological findings. Whole-exome sequencing, electron microscopy, and immunofluorescence mapping were used to identify EB subtypes. Fourteen of the 15 patients recruited initially were confirmed to have EB, while one was excluded due to poor clinicopathological-genetic correlation. Junctional EB (JEB) was identified in 11 patients, with 10 cases linked to a recurrent homozygous pathogenic variant in LAMB3, causing severe JEB, and one to ITGA3 with an unusual variant of interstitial lung disease, nephrotic syndrome, and EB (ILNEB). Two patients had autosomal dominant EB simplex, both with heterozygous KRT14 variants, and one had dominant dystrophic EB associated with a heterozygous COL7A1 variant. Eleven patients presented during the neonatal period, with a mean survival of four weeks, highlighting a high mortality rate, especially in the severe JEB cases. The cohort exhibited a balanced sex distribution, with no clear cases of consanguinity observed. JEB, with a recurrent pathogenic variant in LAMB3, emerged as the predominant subtype among African Zulu patients, underscoring the critical need for early diagnosis and tailored management strategies in resource-limited settings. Integrating clinicopathological and genetic data is essential for accurate diagnosis and prognosis, emphasizing the importance of advanced diagnostic tools in improving outcomes for EB patients in South Africa.

#2

Integrin α3 negative podocytes: A gene expression study.

Matrix biology plus2022 Dec

Integrin α3β1 is a cell adhesion receptor widely expressed in epithelial cells. Pathogenic variants in the gene encoding the integrin α3 subunit ITGA3 lead to a syndrome including interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB). Renal involvement mainly consists of glomerular disease caused by loss of adhesion between podocytes and the glomerular basement membrane. The aim of this study was to characterize the impact of loss of integrin α3 on human podocytes. ITGA3 was stably knocked-out in the human podocyte cell line AB8/13, designated as PodoA3-, and in human proximal tubule epithelial cell line HK2 using the targeted genome editing technique CRISPR/Cas9. Cell clones were characterized by Sanger sequencing, quantitative PCR, Western Blot and immunofluorescence staining. RNASeq of integrin α3 negative cells and controls was performed to identify differential gene expression patterns. Differentiated PodoA3- did not substantially change morphology and adhesion under standard culture conditions, but displayed significantly reduced spreading and adhesion when seed on laminin 511 in serum free medium. Gene expression studies demonstrated a distinct dysregulation of the adhesion network with downregulation of most integrin α3 interaction partners. In agreement with this, biological processes such as "extracellular matrix organization" and "cell differentiation" as well as KEGG pathways such as "ECM-receptor interaction", "focal adhesion" and the "PI3K-Akt signaling pathway" were significantly downregulated in human podocytes lacking the integrin α3 subunit.

#3

A novel ITGA3 homozygous splice mutation in an ILNEB syndrome child with slow progression.

Clinica chimica acta; international journal of clinical chemistry2021 Dec

ILNEB (interstitial lung disease, nephrotic syndrome, epidermolysis bullosa) syndrome is caused by ITGA3 mutations. Demises usually happened at infancy. This study reports a complete ILNEB syndrome child with slow disease progression. Clinical data and related specimens were collected. Genomic DNA was extracted for genetic sequencing. Integrin α3 expression was detected by western blotting and immunofluorescence staining. The patient was male. He experienced recurrent rashes shortly after birth. His sparse eyebrows and eyelashes gradually lost. The patient was vulnerable to respiratory infections and had recurrent fever after vaccine immunization after 4 years. He was found with nephrotic syndrome and polycystic renal dysplasia at 8 years and progressed to end-stage renal disease at 12 years. A chest Computed Tomography revealed intestinal lung disease at 8 years. Continuous oxygen supplementation was needed at 13 years. Counts of lymphocyte subsets revealed elevated percentage of double-negative T cells and activated T cells. Next-generation sequencing revealed a novel homozygous splice mutation c.2219 + 4A > Cin ITGA3 that was predicted to be deleterious. The mutation resulted in exon17 skipping with the loss of 80 bp in the mRNA. The aberrant integrin α3 mRNA level was lower compared to the healthy control. Integrin α3 protein was not detected in urine epithelial cells and skin of the patient. We report a patient harboring a novel ITGA3 homozygous splice mutation who presented with complete ILNEB syndrome but slow disease progression. Immune disorders were suspected.

#4

First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood.

European journal of medical genetics2021 Nov

Interstitial Lung disease, Nephrotic syndrome and Epidermolysis Bullosa, also referred to as ILNEB syndrome is an extremely rare autosomal recessive condition, caused by pathogenic variants in ITGA3. 11 patients have previously been diagnosed with ILNEB syndrome of whom 7 died in infancy or early childhood. We report the only patient with ILNEB syndrome who survived past adolescence, partly due to a double lung transplant. Additionally, our patient showed oral, nasal and gynecological symptoms not previously reported in patients with ILNEB syndrome.

#5

Constitutional absence of epithelial integrin α3 impacts the composition of the cellular microenvironment of ILNEB keratinocytes.

Matrix biology : journal of the International Society for Matrix Biology2018 Dec

Integrin α3β1, a major epidermal adhesion receptor is critical for organization of the basement membrane during development and wound healing. Integrin α3 deficiency leads to interstitial lung disease, nephrotic syndrome and epidermolysis bullosa (ILNEB), an autosomal recessive multiorgan disease characterized by basement membrane abnormalities in skin, lung and kidney. The pathogenetic chains from ITGA3 mutation to tissue abnormalities are still unclear. Although integrin α3 was reported to regulate multiple extracellular proteins, the composition of the extracellular compartment of integrin α3-negative keratinocytes has not been resolved so far. In a comprehensive approach, quantitative proteomics of deposited extracellular matrix, conditioned cultured media as well as of the intracellular compartment of keratinocytes isolated from an ILNEB patient and from normal skin were performed. By mass spectrometry-based proteomics, 167 proteins corresponding to the GO terms "extracellular" and "cell adhesion", or included in the "human matrisome" were identified in the deposited extracellular matrix, and 217 in the conditioned media of normal human keratinocytes. In the absence of integrin α3, 33% and 26% respectively were dysregulated. Dysregulated proteins were functionally related to integrin α3 or were known interaction partners. The results show that in the absence of integrin α3 ILNEB keratinocytes produce a fibronectin-rich microenvironment and make use of fibronectin-binding integrin subunits αv and α5. The most important results were validated in monolayer and organotypic coculture models. Finally, the in vivo relevance of the most dysregulated components was demonstrated by immunostainings of skin, kidney and lung samples of three ILNEB patients.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome nefrótica-doença pulmonar intersticial-epidermólise bolhosa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome nefrótica-doença pulmonar intersticial-epidermólise bolhosa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The Spectrum of Epidermolysis Bullosa in KwaZulu-Natal, South Africa.
    International journal of dermatology· 2025· PMID 40369731mais citado
  2. Integrin &#x3b1;3 negative podocytes: A gene expression study.
    Matrix biology plus· 2022· PMID 36060790mais citado
  3. A novel ITGA3 homozygous splice mutation in an ILNEB syndrome child with slow progression.
    Clinica chimica acta; international journal of clinical chemistry· 2021· PMID 34751145mais citado
  4. First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood.
    European journal of medical genetics· 2021· PMID 34492382mais citado
  5. Constitutional absence of epithelial integrin &#x3b1;3 impacts the composition of the cellular microenvironment of ILNEB keratinocytes.
    Matrix biology : journal of the International Society for Matrix Biology· 2018· PMID 30466509mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:306504(Orphanet)
  2. OMIM OMIM:614748(OMIM)
  3. MONDO:0013881(MONDO)
  4. Sindrome Nefrotica Primaria em Criancas e Adolescentes(PCDT · Ministério da Saúde)
  5. GARD:17377(GARD (NIH))
  6. Variantes catalogadas(ClinVar)
  7. Busca completa no PubMed(PubMed)
  8. Q55784382(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome nefrótica-doença pulmonar intersticial-epidermólise bolhosa
Compêndio · Raras BR

Síndrome nefrótica-doença pulmonar intersticial-epidermólise bolhosa

ORPHA:306504 · MONDO:0013881
🇧🇷 Brasil SUS
Geral
Prevalência
<1 / 1 000 000
Casos
3 casos conhecidos
Herança
Autosomal recessive
CID-10
J84.8 · Outras doenças pulmonares intersticiais especificadas
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C3553636
Repurposing
9 candidatos
chlorthalidonecarbonic anhydrase inhibitor
dexamethasoneglucocorticoid receptor agonist
dexamethasone-acetatesodium/potassium/chloride transporter inhibitor
+6 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades